Target intelligence / Profile preview

CEA cell adhesion molecule pseudogene 4 (CEACAMP4)

Target: CEACAMP4
Molecular classification: Other, Pseudogene

Overview

CEACAMP4 (CEA cell adhesion molecule pseudogene 4) is classified as a human pseudogene in the carcinoembryonic antigen-related cell adhesion molecule family[1][3]. Pseudogenes are segments of DNA that resemble known genes but are generally non-functional and do not encode active proteins. There is no evidence that CEACAMP4 encodes a therapeutic target or participates in biological processes relevant to drug development.

Other names: CEACAM25PCGM11CEA cell adhesion molecule pseudogene 4

Beyond the preview

Go deeper on CEA cell adhesion molecule pseudogene 4 (CEACAMP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEA cell adhesion molecule pseudogene 4 (CEACAMP4).

Explore the full profile